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Abstract: State-of-the-art virus detection technology has advanced a lot, yet technology to evaluate
the impacts of viruses on bee physiology and health is basically lacking. However, such technology
is sorely needed to understand how multi-host viruses can impact the composition of the bee com-
munity. Here, we evaluated the potential of hemolymph metabolites as biomarkers to identify the
viral infection status in bees. A metabolomics strategy based on ultra-high-performance liquid chro-
matography coupled to high-resolution mass spectrometry was implemented. First, we constructed
a predictive model for standardized bumble bees, in which non-infected bees were metabolically
differentiated from an overt Israeli acute paralysis virus (IAPV) infection (R2Y = 0.993; Q2 = 0.906), as
well as a covert slow bee paralysis virus (SBPV) infection (R2Y = 0.999; Q2 = 0.875). Second, two sets
of potential biomarkers were identified, being descriptors for the metabolomic changes in the bee’s
hemolymph following viral infection. Third, the biomarker sets were evaluated in a new dataset
only containing wild bees and successfully discriminated virus infection versus non-virus infection
with an AUC of 0.985. We concluded that screening hemolymph metabolite markers can underpin
physiological changes linked to virus infection dynamics, opening promising avenues to identify,
monitor, and predict the effects of virus infection in a bee community within a specific environment.
Keywords: metabolomics; biomarker; Israeli acute paralysis virus; slow bee paralysis virus; bom-
bus terrestris
1. Introduction
Viruses are etiological agents of diseases and also infect bee species [1]. Understanding
the health impacts of virus–bee interactions, to ultimately identify dangerous bee viral
diseases is critical to safeguard bees [2,3]. The current diagnostic arsenal of virus infection
in bees exhibits high sensitivity (e.g., high-throughput sequencing can detect down to a
single targeted molecule), and new viral sequences are being reported at a higher rate than
ever before [4–6]. However, this raises two questions about bee viral disease monitoring.
First, current methods are predominantly based on pathogen-detection (e.g., binding
properties of antisera and the nucleic acid-based sequencing) [1,6–9], providing limited
insights into the diagnosis of viral disease. In fact, in any bee population or individual
under investigation, viruses are infectious [10,11]. Hence, the detection of viral presence is
not equal to viral disease. Second, there is growing evidence that covert virus infections in
bees is more common than previously expected [1,12], whereby a covert infection can turn
into an overt infection under specific immune-suppressed conditions [13,14]. For instance,
the covert infection by deformed wing virus (DWV) represents a sword of Damocles
permanently threatening the survival of honey bee colonies, and any factors affecting
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the honey bee’s antiviral defences can turn this pathogen into a dangerous killer [13].
Having techniques that can identify/describe these tipping points will allow us to better
understand viral disease progression. To summarize, we need more advanced technologies
to measure the bees’ health or physiological status, to catch up with, and to supplement
the current state of the art viral detection techniques.
Different “omics” technologies exist that describe a specimen’s condition by generating
a massive amount of data. Big data has been suggested to develop predictive models, for
instance, to develop a diagnostic algorithm to identify specimens suffering from some
disease [15]. The metabolome has become widely accepted as a dynamic and sensitive
measure of the phenotype of a species at the molecular level [16,17], and can complement
viral discovery screenings as it provides also insight into the bee’s physiological status.
In addition, viruses are known to influence the metabolism at the cellular level, thereby
disturbing homeostasis of the host metabolism [18,19]. Moreover, for the bumble bee
Bombus terrestris, a metabolic biomarker-based approach showed significant potential to
predict artificial food stress in worker bees [20]. With this rationale, the objective of this
study was to evaluate whether the viral infection status of the bee can be defined based on
the metabolic fingerprint of the bee’s hemolymph.
We used standardized commercial B. terrestris and performed a biomarker discov-
ery study for the Israeli acute paralysis virus (IAPV) and the slow bee paralysis virus
(SBPV). Injection of IAPV in bumble bees leads to high bee mortality within the first week
after injection, while SBPV-infected bees survive, although viral titers increase [21]. An
untargeted metabolomics approach was implemented, based on generic extraction and
ultra-high-performance liquid-chromatography coupled to high-resolution mass spec-
trometry, resulting in a multivariable dataset of unidentified metabolites. We specifically
searched for those metabolites that were most robust to predict a viral infection status.
This was achieved by introducing an additional stressor (i.e., malnutrition) and evaluating
its influence on the predictive power of the model. In addition, we also implemented a
targeted approach that allowed a more mechanistic evaluation of metabolic shifts in the
bee hemolymph in response to the virus, based on metabolite identities. Establishing a
predictive model for standardized bees is considered only a first step towards monitoring
viral damage in bumble bees in natural environments as one can presume that biomarkers
lose their predictive value as the number of variables and additional stressors increase.
Therefore, the predictive value of different biomarker sets was tested for a population
containing only wild bees. We speculate that biologically verified biomarkers, if supported
by literature [19,22,23], will be more likely to maintain their predictive power in wild
bumble bees or to provide some fundamental insights into why predictive power is lost.
2. Materials and Methods
2.1. Insect, Virus, and Injection
All bees had a random age. Commercial bumblebees were randomly picked from
indoor mass-reared queen-right colonies of B. terrestris (Biobest, Westerlo, Belgium). Wild
B. terrestris worker bees were caught in urban areas of Ghent, Belgium during June 2019.
Upon arrival in the lab, five random worker bees (commercial or wild) were placed in
one microcolony. In total, we started 48 microcolonies (40 with commercial and 8 with
wild-caught bees). These microcolonies were placed in an incubator at 30 ◦C, 60% rela-
tive humidity, and continuous darkness, and were all fed with gamma-irradiated pollen
(Apihurdes, Pinofranqueado, Spain); 20 + 4 microcolonies (commercial or wild) received
a standardized sugar syrup (50 w/v %, BIOGLUC, Biobest), while the other 20 + 4 micro-
colonies (commercial or wild) received a 25% sugar syrup to mimic a low carbohydrate
nutritional stress [24]. Bees were kept in these conditions for one week. To establish
a systematic infection, the virus was injected into the bee’s hemocoel using a Femtojet
Microinjector (Eppendorf, Hamburg, Germany). IAPV and SBPV inocula were produced
by propagating virus reference isolates in 50 white-eyed honeybee pupae and preparing
a chloroform-clarified extract in phosphate buffer saline (PBS) (10 mM phosphate buffer
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(pH 7.0)/0.02% diethyl dithiocarbamate) by following the same protocol as described
previously [25]. Prior to injection, the IAPV stock was diluted 10,000 times and the SBPV
stock was diluted 50 times in a filter-sterilized phosphate buffer saline (PBS). Bees were
firstly immobilized on ice for 2 min, and 5 µL of IAPV (~500 virus particles), 5 µL of
SBPV (~1 × 105 virus particles), or 5 µL of filter-sterilized PBS was injected through the
membrane between the second and third segment in the abdomen. The IAPV and SBPV
stocks were provided by Joachim de Miranda (Swedish University of Agricultural Sciences,
Uppsala, Sweden). Both virus stocks were stored in aliquots at –80 ◦C and had an estimated
number of 1 × 106 particles per mL (measured by transmission electron microscope). In
addition, virus stocks had < 0.1% contamination of other common honeybee viruses, as
determined by RT-qPCR [26].
2.2. Hemolymph Collection
Bee hemolymph was collected by making a small incision in the dorsal thorax and
extracting 10 µL per bee using Wiretrol II Capillary micropipettes (VWR) into an Eppendorf
tube that contained 2 µL of 5% N-phenylthiourea (PTU, w/v; Sigma Aldrich, Overijse,
Belgium) in 1 mL of 50% methanol/PBS to prevent melanization. The hemolymph sample
was collected on ice and immediately put on dry ice afterwards. All hemolymph collection
was performed under binocular microscope, and three rules were strictly followed to
guarantee the quality of sampling: (i) the hemolymph should be pure and transparent;
(ii) no other tissues were perforated; (iii) sampling time (incision and extraction) per bee is
less than 35 s. All samples were stored at −80 ◦C until chemical analysis.
2.3. Extraction of Polar and Medium Polar Metabolites from Bee Hemolymph
Polar and medium polar metabolites were extracted from bee hemolymph as previously
described [20]. In brief, 40 µL of methanol-ethyl acetate mixture was used for extraction of
polar metabolites and precipitation of proteins. In addition, 5 µL valine-d8 internal standard
solution (ISTD, 25 ng/µL in ultrapure water) was pre-added. Subsequently, samples were
incubated for 30 min at 4 ◦C to enhance protein precipitation and centrifugated at 15,000× g
for 15 min at 4 ◦C to remove the resulting precipitate. Ultimately, the supernatant was
transferred to a 1.5-mL microfuge tube and consecutively dried using the Speed-Vac. All
dried samples were suspended in 100 µL ultrapure water and transferred to an liquid-
chromatography–mass spectrometry (LC-MS) vial with glass insert. Solvents used for
extraction of hemolymph metabolites were of LC-MS grade, obtained from Fisher Scientific
(Loughborough, UK) and VWR International (Merck, Darmstadt, Germany). Ultrapure
water was obtained by usage of a purified-water system (VWR International, Merck).
2.4. UHPLC-Q-Orbitrap-HRMS Analysis
For ultra-high-performance LC hyphenated to Quadrupole-Orbitrap high-resolution
MS (UHPLC-Q-Orbitrap-HRMS) analysis, the methodology used was as previously de-
scribed [18]. The chromatographic separation was performed using an Ultimate 3000 XRS
UHPLC system (Thermo Fisher Scientific, San José, CA, USA). An Acquity UPLC HSS-T3
column (1.8 µm, 150 mm × 2.1 mm) (Waters, Manchester, UK), kept at 45 ◦C, was used, to
which a binary solvent system consisting of ultrapure water (A) and acetonitrile (B), with
both acidified with 0.1% formic acid, was applied at a constant flow rate of 0.4 mL/min.
All solvents used were of LC-MS grade and obtained from Fisher Scientific and VWR
International (Merck). Ultrapure water was obtained by usage of a purified-water system
(VWR International, Merck). Mass analysis was performed on a Q-ExactiveTM Orbitrap
mass analyzer (Thermo Fisher Scientific) that was equipped with a heated electrospray
ionization (HESI II) source, operating in polarity switching mode. Hereby, full-scan events
were applied at a mass resolution of 70,000 full width at half maximum. A pool of all ex-
tracts (n = 150) was used to make quality control (QC) samples for instrument conditioning
and data normalization. Experimental samples were run in a randomized order, except for
QC samples, which were analyzed in duplicate after every nine experimental samples.
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2.5. Predictive Modelling of Viral Infection in Standardized Bees
2.5.1. Experimental Setup
We randomly assigned 200 commercial bees to 40 microcolonies consisting of four
treatment groups, including PBS-injected bees, IAPV-injected bees, SBPV-injected bees,
and mock bees (without any treatment). For each group, we also introduced the stressor
malnutrition (bees fed on either normal 50% or stress 25% sugar syrup). In total, we
sampled 110 bees for hemolymph extraction (i.e., in total three bees per microcolony one at
day 2, day 4, and day 14 post virus injection, except for IAPV treated bees where we had
only two sampling points since bees are dead 7 days post injection).
The choice of our sampling timepoint was based on previously established infection
dynamics for IAPV and SBPV in commercial bumble bees. IAPV has a quick replication,
resulting in high mortality in the first week, while SBPV has a steep increase in the first
week, with a more moderate growth later and no mortality [21]. We opted to have a
sampling point in an early and a later stage of the infection. We sampled IAPV from early
infected bees 2 days post infection (2DPI, no dead bees at that moment) and late infected
bees 4 days post infection (4DPI, with a fraction of bees already dead), and only considering
bees without clear paralysis symptoms. For SBPV-infected bees, we selected the same
sampling times of 2DPI and 4 DPI as these can be considered as the early stages of the
infection. In addition, for SBPV we also sampled bees at 14 days post-infection (14DPI) as
the late stage of infection.
2.5.2. Data Analysis and Biomarker Selection
Untargeted data analysis was performed as previously described by Wang et al.
2019 [19]. Briefly, LC-MS raw data were imported into Sieve 2.1 software package (Thermo
Fisher Scientific) for peak extraction and alignment, deconvolution, and noise removal.
This rendered a list of metabolite components (clustered features). The coefficient of
variation (CV) was calculated for each component in the collection of QC samples, and
only components with CV lower than 30%, which is considered an acceptable value of
repeatability in untargeted metabolomics, were retained [27,28]. To correct for potential
instrumental drift during analysis, the abundance of each component in a sample was
divided by the corresponding mean abundance, as calculated for the two QC samples
following that sample [29]. To assess the metabolic differences between the samples sets,
unsupervised principal component analysis (PCA-X) and supervised pairwise OPLS-DA
analyses were performed using SIMCA® 14.1 multivariate statistics software (Umetrics,
Malmo, Sweden). Model validation was performed through various quality parameters
such as CV-ANOVA (p-value < 0.05), permutation testing (n = 100), Q2 (>0.5), and R2Y
(>0.5) [30]. S-plots were built using validated OPLS-DA models to select components
that are important for classifying bees with different levels of viral infection. Additional
filtering of components was achieved using the variable importance in projection (VIP)
score, for which a threshold of >1.5 was set.
Targeted data analysis was performed using XcaliburTM 2.1 (Thermo Fisher Scientific),
allowing quantitative analysis (peak integration) of metabolites that were identified based
on the mass spectrum (m/z-value and 13C isotope profile) and retention time. Hereby, the
identification process was based on an in-house library of analytical standards (±300 com-
pounds), which were injected through various mixtures at the beginning of the analytical
sequence. Statistical analysis was performed using SPSS 22.0 software, applying two-way
ANOVA and Tukey HSD test for post-hoc comparisons, whereby a p-value < 0.05 was
considered as statistically significant. Further filtering of candidate biomarkers was based
on biological qualification, performing literature survey and metabolic pathway analysis
(MetaboAnalyst, http://www.metaboanalyst.ca/ (accessed on 1 March 2021)). To judge
the overall diagnostic efficacy of the selected metabolites in the standardized bee dataset,
we calculated the AUC value using ROC curve analysis in MetaboAnalyst.
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2.6. Predictive Potential of 2 Sets of Biomarkers in Wild Bumble Bees
The 40 wild caught B. terrestris were randomly assigned to the four treatment groups,
including PBS-injected bees, IAPV-injected bees, SBPV-injected bees, and mock bees. To
evaluate the predictive power of the candidate biomarker sets, we used different machines
learning classification algorithms, performed in Waikato Environment for Knowledge
Analysis (WEKA, version 3.8.4) [31]. The selected classifier was the random forest algorithm.
Models were built with a single biomarker set or a combination of two biomarker sets.
The 10-fold cross validation method was used during the training process, and then the
classification accuracy was computed to represent the overall performance for each model.
3. Results and Discussion
Upon analysis of 150 hemolymph samples, obtained from B. terrestris hemolymph
following different virus infections, nutritional stresses, and sample resources (commer-
cially available and wild-caught), a total of 1149 (+ionization mode) and 911 (−ionization
mode) components were defined as constituents of the metabolic fingerprint. The PCA-X
score plots revealed good clustering of the internal QC samples (Figure 1), confirming good
instrumental stability during sample analysis.
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3.1. Untargeted Data Analysis
In Table 1, we present an overview of OPLS-DA model performance in the commercial
bumble bee dataset (n = 110). We performed multiple pairwise comparisons of various
treat ent groups.
3.1.1. Predictive Modelling of Viral Infection in Non-Stressed Commercial Bees
We first analyzed if the viral infection status can be discriminated in standardized
commercial bees, without any additional stressor, as stressors could potentially obscure
clear virus related metabolome fingerprints. In bees receiving 50% sugar water, models
had a predictive power to (1) find an overt (IAPV) and covert (SBPV) infection (Table 1,
model 5 for IAPV, model 9 for SBPV) and (2) discriminate between the two viruses (Table 1,
model 15). These results revealed that UHPLC-Orbitrap-MS-based metabolomics could
successfully establish and distinguish the metabolic fingerprints of virus-infected bees
from that of the non-virus-infected PBS controls, even in the asymptomatic SBPV covertly-
infected bees.
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Table 1. Classification dataset composition and specification of constructed Orthogonal Projections to Latent Structures Discriminant Analysis (OPLS-DA) models, with output of the
model validation procedure. OPLS-DA models were based on quality control (QC)-normalized data.
Model Comparison Model Specification Numbers of ModelComponents (to + tp) a
Model Characteristics b p-value Cross-Validated ANOVA c Permutation d
Virus
1 25% diet: virus (n = 25) vs. non-virus (n = 30) Virus - e - - No
2 50% diet: virus (n = 25) vs. non-virus (n = 30) Virus 1 + 4 + 0 R2Y = 0.97; Q2 = 0.741 6.10 × 10−10 Good
3 All: virus (n = 50) vs. non-virus (n = 60) Virus - - - No
IAPV
4 25% diet: IAPV (n = 10) vs. PBS (n = 10) IAPV - - - No
5 50% diet: IAPV (n = 10) vs. PBS (n = 10) IAPV 1 + 3 + 0 R2Y = 0.995; Q2 = 0.906 2.80 × 10−5 Good
6 All: 4DPI (n = 10) vs. 2DPI (n = 10) Time 1 + 5 + 0 R2Y = 0.999; Q2 = 0.875 1.75 × 10−3 Good
7 All: IAPV (n = 20) vs. PBS (n = 20) IAPV 1 + 5 + 0 R2Y = 0.993; Q2 = 0.905 1.01 × 10−10 Good
SBPV
8 25% diet: SBPV (n = 15) vs. PBS (n = 15) SBPV - - - No
9 50% diet: SBPV (n = 15) vs. PBS (n = 15) SBPV 1 + 4 + 0 R2Y = 0.995; Q2 = 0.931 6.49 × 10−9 Good
10 All: 4DPI (n = 10) vs. 2DPI (n = 10) Time 1 + 4 + 0 R2Y = 0.997; Q2 = 0.883 3.81 × 10−4 Good
11 All: 14DPI (n = 10) vs. 2DPI (n = 10) Time 1 + 2 + 0 R2Y = 0.970; Q2 = 0.871 4.11 × 10−5 Good
12 All: 14DPI (n = 10) vs. 4DPI (n = 10) Time 1 + 7 + 0 R2Y = 1.000; Q2 = 0.863 2.00 × 10−2 Good
13 All: SBPV (n = 30) vs. PBS (n = 30) SBPV 1 + 9 + 0 R2Y = 0.996; Q2 = 0.694 3.66×10−5 Good
IAPV vs. SBPV
14 25% diet: SBPV (n = 10) vs. IAPV (n = 10) SBPV/IAPV 1 + 4 + 0 R2Y = 0.996; Q2 = 0.827 2.77 × 10−3 Good
15 50% diet: SBPV (n = 10) vs. IAPV (n = 10) SBPV/IAPV 1 + 1 + 0 R2Y = 0.958; Q2 = 0.849 5.14 × 10−6 Good
16 All: SBPV (n = 30) vs. IAPV (n = 20) SBPV/IAPV 1 + 5 + 0 R2Y = 0.984; Q2 = 0.811 5.67 × 10−10 Good
a with the orthogonal and the predictive component; b with R2Y the variation in Y that is explained by the model, and Q2 the predictive ability of the model. Q2 > 0.5 indicated good model quality [32];
c a cross-validated ANOVA p-value < 0.05 indicated good model quality; d good permutation testing was achieved if R2Y and Q2 values of the models based on the permutated data were significantly lower than
those based on the real data set; e this model cannot be validated.
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3.1.2. Predictive Modelling of Viral Infection in Stressed Commercial Bees
To select a robust set of biomarkers that have the potential to identify virus infection
status in wild bees, the predictive framework must work in bees that are confronted with
different stressors. To simulate this, we added a nutritional stressor to the standardized bee
test group. We chose nutritional stress, which has been demonstrated to have synergistic
effects to virus infection [33,34]. When bees were subjected to this diet stress, discrimination
according to bee’s infection status was no longer possible (Table 1, model 4 for IAPV, model
8 for SBPV). This substantiates the results of our previous study; a 25% sugar concentration
may cause significantly disturbed metabolic effects in the bee hemolymph [20]. Interest-
ingly, when we combined the 25% and 50% sugar water treatment, the models regained
their predictive power to (1) find a viral infection (Table 1, model 7 for IAPV, model 13 for
SBPV); (2) discriminate between viruses (Table 1, model 7 for IAPV, model 16 for SBPV);
and (3) discriminate between early and late infection stage (Table 1, model 6 for IAPV,
model 10–12 for SBPV).
3.1.3. Biomarker Selection to Discriminate Infection in Wild Bees
Although we cannot discriminate the viruses in stressed (malnourished) bees, our
results confirmed that UHPLC-Orbitrap-MS-based metabolomics can clearly distinguish
bees with or without virus infection in many situations (from single virus-infected bees to
a mixture of single- and double-stressed bees). To select robust biomarkers, we defined
components with discriminative power (meaning VIP > 1.5 in predictive models of Table 1).
For each virus we selected those markers that were able to (1) identify viral infection
(model 2), (2) identify which virus infected (models 5 and 9), and (3) identify which virus
infected in the dataset including stressed bees (model 7 and 13). The predictive power (Q2)
of model 13 is lower, meaning that including stressed bees indeed make the classification
harder. This selection strategy resulted in five potential biomarkers for IAPV infection
(Figure 2A) and three potential biomarkers for SBPV infection (Figure 2B). Together, these
eight components were further assigned as the “untargeted biomarker set”.
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Figure 2. Biomarker Venn diagram. (A) Five Israeli acute paralysis virus (I )-r l t iomarkers:
the overlap between three circles defines the number of markers chosen by model 2 (virus vs. non-
virus), model 5 (IAPV vs. phosphate buffer saline (PBS), with 50% diet), and model 7 (IAPV vs. PBS,
all). (B) Three slow bee paralysis virus (SBPV)-related biomarkers: the overlap between three circles
defines the number of markers chosen by model 2 (virus vs. non-virus), model 9 (SBPV vs. PBS, with
50% diet), and model 13 (SBPV vs. PBS, all). The general idea behind this selection is to select the
most robust biomarkers related to IAPV or SBPV infection, even with variables from diets.
3.2. Targeted Data Analysis
Based on our in-house library of 300 metabolites, we were able to identify 76 metabo-
lites in the hemolymph of commercial bees (for an overview of these metabolites, see
supplementary information Table S1). The identity of the metabolites allowed us to make
an informed decision on the potential of a discriminating metabolite as a biomarker, by pro-
viding a biological insight on what is happening in the infected bee, for instance, whether
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there is a direct or indirect mechanistic link to the effects of the virus or if the marker is also
associated with other stressors of bees. We followed a three-step approach to select biologi-
cally relevant biomarkers: (1) metabolites were selected that were significantly correlated
to infection stage, (2) on this list of metabolites a pathway analysis was performed, and (3)
a literature search was performed to identify potential viral specific signatures. The results
are summarized in supplementary information S1 (Tables S2 and S3 and Figure S1). The
majority of the virus-disturbed metabolic pathways are related to amino acid biosynthesis,
amino acid degradation, and aminoacyl-tRNA biosynthesis (supplementary information S1,
Tables S2 and S3). Amino acids are key components in bee hemolymph [35,36], and in
total we identified 17 amino acids in the hemolymph. Principal component analysis with
these 17 amino acids showed that viral infection stadia can be separated, and essential and
non-essential amino acids vectors are correlated within but not amongst each (Figure 3).
The ratio of essential and non-essential amino acids is thus disturbed in relation to virus
infection, with amino acid metabolism known to be important for viral replication [23,37].
It has been reported that viruses can modify the host amino acids production to promote
viral genome replication [22]. Such a stimulus could result in altered ratios of essential
versus non-essential amino acids (the latter being those produced by the host).




Figure 3. Principal component analysis (PCA-X) of essential and non-essential amino acids in rela-
tion to virus infection (SBPV or IAPV) and exposure time (2DPI and 4DPI) in bees with a normal 
food regime (50% sugar). Small dots represent the actual datapoints; the bigger dots represent the 
center of the ellipses with a 95% confidence level. 
A second important group of metabolites we observed were the polyamines: spermi-
dine, spermine, cadaverine, and putrescine, to see if they were differentially expressed 
(supplementary information S1 Figure S1). They were included as biological relevant 
markers, as dysregulation of cellular polyamines have been associated with various 
pathological conditions including viral infections [38]. Polyamines play a role in viral en-
try, transcription, replication, and virion packaging [39]. They neutralize negative 
charges, which are useful to package the negatively charged viral genome into the virion 
[40]. From the host’s perspective, polyamines play a role in nucleotide and lipid metabo-
lism and reactive oxygen species production [39]. We see no clear pattern in levels of pol-
yamines in relation to virus and infection stage; this can be explained as we cannot differ-
entiate between the polyamines sequestered in the virions and those available to host. 
Together, these 21 components (17 amino acids and 4 polyamines) are further on 
named as the ‘’targeted biomarker set’’. In the commercial bees, the AUC of this biomarker 
set to identify a viral infection was 0.876 (95% CI: 0.783–0.949). 
3.3. Predictive Power of the Biomarker Set 
In Table 2, we describe the predictive power, with the classifying algorithm random 
forest, in a group of 40 wild bees. The untargeted and targeted biomarker set had good 
diagnostic performance for discriminating IAPV, SBPV, and general virus infection in 
standardized commercial bees. Both sensitivity (ratio of true positives over the sum of 
true and false positives) and precision (ratio of true positives over the sum of true posi-
tives and false negatives) increased when we used the targeted biomarkers, yet this effect 
could be due to the higher number of components in this set. Overall, the marker signa-
tures had good classification power, identifying viral infection but also being able to dif-
ferentiate between a virulent IAPV and a less virulent SBPV infection. We would like to 
point-out that classification was not based on absolute concentrations or thresholds of the 
Figure 3. Principal component analysis (PCA-X) of essential and non-essential amino acids in relation
to virus infection (SBPV or IAPV) and exposure time (2DPI and 4DPI) in bees with a normal food
regime (50% sugar). Small dots represent the actual datapoints; the bigger dots represent the center
of the ellipses with a 95% confidence level.
A second important group of metabolites we observed were the polyamines: sper-
midine, spermine, cadaverine, and putrescine, to see if they were differentially expressed
(supplementary information S1 Figure S1). They were included as biological relevant
markers, as dysregulation of cellular polyamines have been associated with various patho-
logical conditions including viral infections [38]. Polyamines play a role in viral entry,
transcription, replication, and virion packaging [39]. They neutralize negative charges,
which are useful to package the negatively charged viral genome into the virion [40]. From
the host’s perspective, polyamines play a role in nucleotide and lipid metabolism and
reactive oxygen species production [39]. We see no clear pattern in levels of polyamines
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in relation to virus and infection stage; this can be explained as we cannot differentiate
between the polyamines sequestered in the virions and those available to host.
Together, these 21 components (17 amino acids and 4 polyamines) are further on
named as the “targeted biomarker set”. In the commercial bees, the AUC of this biomarker
set to identify a viral infection was 0.876 (95% CI: 0.783–0.949).
3.3. Predictive Power of the Biomarker Set
In Table 2, we describe the predictive power, with the classifying algorithm random
forest, in a group of 40 wild bees. The untargeted and targeted biomarker set had good
diagnostic performance for discriminating IAPV, SBPV, and general virus infection in
standardized commercial bees. Both sensitivity (ratio of true positives over the sum of true
and false positives) and precision (ratio of true positives over the sum of true positives and
false negatives) increased when we used the targeted biomarkers, yet this effect could be
due to the higher number of components in this set. Overall, the marker signatures had
good classification power, identifying viral infection but also being able to differentiate
between a virulent IAPV and a less virulent SBPV infection. We would like to point-out
that classification was not based on absolute concentrations or thresholds of the suggested
markers, and that wild and standardized bees had different levels of the biomarkers.
Table 2. Performance of diagnostic support models with Random Forest constructed using different
candidate biomarkers for wild bees.
Features Discrimination Sensitivity Precision AUC
Untargeted (n = 8)
Virus vs. Non-virus 77.5% 77.6% 0.892
IAPV vs. Non-virus 86.7% 88.9% 0.955
SBPV vs. Non-virus 80.0% 79.5 0.815
Amino acids + polyamines
(n = 21)
Virus vs. Non-virus 90.0% 90.0% 0.945
IAPV vs. Non-virus 93.3% 93.3% 0.985
SBPV vs. Non-virus 90.0% 89.9% 0.875
Combined (n = 29)
Virus vs. Non-virus 90.0% 90.0% 0.948
IAPV vs. Non-virus 90.0% 89.9% 0.985
SBPV vs. Non-virus 83.3% 83.1% 0.930
The normalized mass spectral ion intensities of the untargeted and targeted biomarker candidates were used,
marking IAPV, SBPV and non-virus infection. Ten-fold cross-validation was used.
4. Conclusions
In summary, this study provided the first evidence of biomarker discovery for predict-
ing virus infection in bees. A dual targeted and untargeted metabolomics approach was
established to analyze both covert and overt virus infection in B. terrestris. Twenty-nine
metabolites (i.e., 21 identified and eight unidentified metabolites) were finally selected
as potential biomarkers, descriptive for virus infection. There is growing evidence that
the impacts of viruses on their bee hosts can be exacerbated by poor nutrition [33,41];
hence, a nutritional stress parameter was incorporated. It remains to be determined if the
biomarker sets can differentiate natural infections in different environments encompassing
different stressors impacting general bee health. Yet, we were able to demonstrate good
diagnostic performance in standardized and wild bees in which these stressors were artifi-
cially induced. Our results showed the potential of a metabolic biomarker-based approach
to classify virus infection. Moving forward, large-scale independent validation studies
conducted in laboratory and field settings using independent cohorts are necessary to
refine and validate our metabolomics-based biomarkers of virus infection in bees. Datasets
linking information of the bee hemolymph metabolome and its physiological status, to-
gether with virus titers and virus tissue tropisms, will further improve our understanding
of the impact of different viruses in different bee species. The next step is to describe these
complex multi-host, multi-virus assemblies. Unlike transcriptome or proteome markers,
which are diversified from species to species, metabolite composition is highly similar
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between species. This underlines the potential of metabolite biomarkers to be adequate in a
broader set of bees, and to function as tools to describe the health of a community foraging
within a specific environment.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/v13040600/s1, Figure S1: Abundance analysis of four polyamines detected in 50% sugar syrup-
fed bee hemolymph. Table S1: Peak abundance ratio of identified metabolites in bee hemolymph
between 25% sugar syrup and control, Table S2: Significantly disturbed pathways in IAPV-infected
bees (IIB), Table S3: Significantly disturbed pathways in SBPV-infected bees (SIB).
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